Company:  NATERA, INC. (NTRA)
Form Type:  8-K
Filing Date:  8/5/2021 
CIK:  0001604821 
Address:  13011 MCCALLEN PASS
BUILDING A SUITE 100
 
City, State, Zip:  AUSTIN, Texas 78753 
Telephone:  650-249-9090 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$114.19  
Change: 
1.87 (1.67%)  
Trade Time: 
11:25 AM EST  
Market Cap: 
$10.71B
Trade NTRA now with 

© 2021  
Description of Business
We are a diagnostics company with proprietary molecular and bioinformatics technology that we are applying to change the management of disease worldwide. Our cell-free DNA, or cfDNA, technology combines our novel molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell, with our statistical algorithms which incorporate data available from the broader scientific community to identify genetic variations covering a wide range of serious conditions with best-in-class accuracy and coverage. Our technology has been proven clinically and commercially in the women's health space, in which we develop and commercialize non- or minimally- invasive tests to evaluate risk for, and thereby enable early detection of, a wide range of genetic conditions, such as Down syndrome.
Register and access this filing in:     
  FORM 8-K
    SECTION 2 FINANCIAL INFORMATION
      Item 2.02. Results of Operations and Financial Condition.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 99.1
    BALANCE SHEET
    INCOME STATEMENT
  EXHIBIT 99.2